Arizona State Retirement System Purchases 810 Shares of NextGen Healthcare, Inc. (NASDAQ:NXGN)

Arizona State Retirement System grew its holdings in shares of NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) by 5.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 16,314 shares of the company’s stock after purchasing an additional 810 shares during the period. Arizona State Retirement System’s holdings in NextGen Healthcare were worth $306,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Point72 Hong Kong Ltd purchased a new position in shares of NextGen Healthcare during the third quarter valued at approximately $40,000. Captrust Financial Advisors lifted its holdings in shares of NextGen Healthcare by 61.5% during the first quarter. Captrust Financial Advisors now owns 4,255 shares of the company’s stock valued at $89,000 after purchasing an additional 1,620 shares during the last quarter. UBS Group AG lifted its holdings in shares of NextGen Healthcare by 211.1% during the third quarter. UBS Group AG now owns 6,639 shares of the company’s stock valued at $118,000 after purchasing an additional 4,505 shares during the last quarter. TD Asset Management Inc purchased a new position in shares of NextGen Healthcare during the fourth quarter valued at approximately $192,000. Finally, Citadel Advisors LLC purchased a new position in shares of NextGen Healthcare during the second quarter valued at approximately $200,000. 73.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on NXGN shares. Piper Sandler decreased their price objective on shares of NextGen Healthcare from $20.00 to $17.00 in a report on Thursday, May 18th. TheStreet lowered shares of NextGen Healthcare from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. StockNews.com started coverage on shares of NextGen Healthcare in a report on Thursday, May 18th. They issued a “buy” rating for the company. Stephens started coverage on shares of NextGen Healthcare in a report on Tuesday, April 11th. They issued an “overweight” rating and a $24.00 price objective for the company. Finally, Truist Financial decreased their price objective on shares of NextGen Healthcare from $22.00 to $18.00 in a report on Monday. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, NextGen Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $21.00.

NextGen Healthcare Price Performance

Shares of NXGN opened at $15.64 on Tuesday. The firm has a market cap of $1.03 billion, a PE ratio of -391.00 and a beta of 1.04. The company has a current ratio of 2.03, a quick ratio of 2.53 and a debt-to-equity ratio of 0.67. The firm has a fifty day simple moving average of $17.07 and a two-hundred day simple moving average of $18.21. NextGen Healthcare, Inc. has a 1-year low of $15.23 and a 1-year high of $21.99.

About NextGen Healthcare

(Get Rating)

NextGen Healthcare, Inc provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange.